Trial Profile
A Phase II Trial of LY317615 in Patients With Recurrent High-Grade Gliomas
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 04 Aug 2016
Price :
$35
*
At a glance
- Drugs Enzastaurin (Primary)
- Indications Glioma
- Focus Therapeutic Use
- Sponsors Eli Lilly and Company
- 05 Nov 2005 New trial record.